Luis Felipe Cardona Polo

Mr. Luis Felipe Cardona Polo


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Environments
Verified
Journal Article
Open access
PDF file
AHAbigail Hall
Abigail Hall
LPLuis Felipe Cardona Polo
Luis Felipe Cardona Polo
KHKennedy Helms
Kennedy Helms
ACAlexei Christodoulides
Alexei Christodoulides
NANathan J. J Alves
Nathan J. J Alves
Microplastic pollution poses an increasing environmental and human health risk and additional techniques are needed to facilitate nondestructive, quantitative particle recovery and analysis. Using a mini-extruder filtration (MEF) device, the efficiency of pristine particle capture from solution and digested biological tissue (blood clots) was assessed. Polystyrene particles in both the submicron (100, 300, and 500 nm) and micron range (2, 5, 7, and 10 µm) with aminated, carboxylated, or unmodified surface modifications were explored. The MEF-isolated-particle recovery was analyzed pre- and postseparation isolation and quantified via a Nanosight LM10 particle tracking system (submicron particles) or hemacytometer (micron particles). Particles’ surface chemistry and concentration did not impact recovery compared to unfiltered samples with smaller particle sizes reducing recovery efficiency. Micron particle size recovery averaged 86.8 ± 4.3% across all surface chemistries at the same concentration; however, submicron particle recoveries varied by size and charge with 500 nm exhibiting recoveries of 80.6 ± 16.6%, 300 nm 73.0 ± 10.4%, and 100 nm particles 17.0 ± 10.3%. The mini-extruder device, used as a filtration recovery system, efficiently captures 10 to 0.5 µm particles from environmental and tissue samples making it an effective and low-cost platform facilitating the nondestructive capture of diverse microplastics for subsequent analysis.

Verified
Journal Article
Open access
PDF file
PGPaola Marie Ortiz Gonzalez
Paola Marie Ortiz Gonzalez
AMAnna M. Miller
Anna M. Miller
LPLuis Felipe Cardona Polo
Luis Felipe Cardona Polo
LPLilian Irene Plotkin
Lilian Irene Plotkin
FPFabrizio Pin
Fabrizio Pin
JHJoshua Huot
Joshua Huot
Lung cancer is a leading cause of death worldwide and is often accompanied by declines in musculoskeletal health (i.e., cachexia). Despite affecting a majority of lung cancer patients, cachexia remains understudied and currently has no cure. We have previously demonstrated that liver metastases (LMs) exacerbate cachexia in murine models of colorectal cancer, and, while the liver represents a common site of metastases and is associated with poor prognosis in patients with lung cancer, whether LMs heighten musculoskeletal wasting in mice bearing lung cancer is unknown. Here, we aimed to characterize the impact of LMs on musculoskeletal health in a mouse model of lung cancer cachexia. C57BL/6J male mice were injected with LLC tumor cells either subcutaneously or intrasplenically (LMs) to mimic hepatic metastases (n = 6–9/group). Upon sacrifice, skeletal muscle, bone, and plasma were collected for morphological and molecular analyses. Consistently, compared to healthy controls, metastatic tumor hosts displayed greater reductions in muscle weights (~17%), in line with decreased muscle torque (~23%) and reduced muscle cross-sectional area (~10%). On a molecular level, skeletal muscle from mice bearing LMs had elevated levels of pStat3, Murf1, and Atrogin-1, suggesting enhanced protein catabolism. Similar to skeletal muscle, metastatic tumor hosts displayed greater losses in trabecular bone and increased skeletal fragility. Plasma proteomics identified 211 and 131 differentially expressed proteins in metastatic hosts compared to control animals and subcutaneous LLC hosts, respectively. Top regulated pathways in mice bearing LMs included neutrophil degranulation, BAG2 signaling, and cachexia signaling. Overall, our findings demonstrate that LMs are accompanied by accelerated musculoskeletal wasting and weakness in a mouse model of lung cancer cachexia. This work highlights the need for animal models that mimic advanced cancer, thus providing a better understanding of the mechanisms that mediate cachexia.